Feb 25, 2019
Actinium's Late Breaking Oral Presentation at 2019 TCT Meetings Reports New Data on Donor Chimerism Indicating Deep Engraftment in All Iomab-B Treated Patients in the Pivotal Phase 3 SIERRA Trial
Feb 22, 2019
Roswell Park Presentations at TCT Meeting Focus on Tools for Predicting Patient Outcomes
Feb 19, 2019
Arix Bioscience plc: Autolus Announces Updated Results From CARPALL Trial
Feb 19, 2019
Autolus Therapeutics Announces Updated Results from Ongoing CARPALL Trial of Pediatric Acute Lymphoblastic Leukemia Presented at the EHA 1st European CAR T Cell Meeting in Paris
Feb 12, 2019
Iomab-B One of Four Late Breaking Oral Presentations to be Presented at the 2019 Transplantation & Cellular Therapy Annual Meeting
Feb 05, 2019
Cellect Begins Collaboration with Washington University in Preparation for First U.S. Clinical Trial Using Cellect's ApoGraft(TM) for Bone Marrow Transplantations
Jan 29, 2019
Actinium Pharmaceuticals to Host Key Opinion Leader Breakfast on Targeted Conditioning for Bone Marrow Transplant and CAR-T on February 7th
Jan 16, 2019
BlueRock Therapeutics Establishes Key Partnerships with Leading Experts in Autoimmune Disease
Dec 13, 2018
Newly Published Case Series Demonstrates the Karius Test's Effectiveness for Monitoring Infections in Stem-Cell Transplant Patients at Risk of Infections
Dec 04, 2018
Actinium Pharmaceuticals Highlights Analysis of Pivotal Iomab-B Phase 3 SIERRA Trial Presented in Oral Session at ASH Annual Meeting
Dec 03, 2018
Data Presented at ASH Support Emapalumab as an Innovative, Targeted Therapeutic Option for Primary HLH
Dec 03, 2018
EHA and EBMT Joint Meeting on CAR T Cells, First of its Kind in Europe
Dec 02, 2018
Studies Offer Glimpses into the Future of Medicine
Nov 29, 2018
It's Not Over: More Ethnically Diverse Donors Urgently Needed
Nov 28, 2018
Jazz Pharmaceuticals to Highlight Hematology Research at ASH 2018 Annual Meeting
Nov 15, 2018
Sickle Cell Disease Treatment Market Worth $5.5 Billion by 2023 | CAGR: 14.3%: Grand View Research, Inc.
Nov 01, 2018
Actinium Pharmaceuticals ASH Annual Meeting Presence to Include Oral Presentation of Feasibility and Safety Results of Iomab-B Pivotal Phase 3 SIERRA Trial and also New Actimab-A Phase 2 Trial Data
Oct 15, 2018
Cellect Announces Positive Clinical Results
Sep 27, 2018
Automated NGS-based HLA Typing and Epitope Matching at the 44th ASHI Annual Meeting 2018
Sep 13, 2018
NIH launches initiative to accelerate genetic therapies to cure sickle cell disease